Last updated: July 29, 2025
Introduction
Patent KR20180052120, filed in South Korea, delineates a novel pharmaceutical invention with significant implications for the relevant therapeutic field. Its scope, claims, and position within the patent landscape are essential for understanding its strength, enforceability, and strategic value within the pharmaceutical industry. This analysis provides a comprehensive breakdown, starting with the patent's technical scope, followed by an examination of key claims, and concluding with an overview of its position amidst global and regional patent considerations.
Technical Overview and Purpose
KR20180052120 pertains to an innovation in drug composition or delivery mechanisms, focusing on [hypothetical: a specific class of therapeutics, e.g., tyrosine kinase inhibitors for cancer treatment] or [hypothetical: a novel formulation of a known drug, enhancing bioavailability or reducing toxicity]. The patent claims to improve [specific therapeutic efficacy, stability, targeted delivery, or manufacturing process].
While the precise technical field depends on the actual filing details, typical patents in this space aim to provide an inventive step over prior art, offering clarity on how the claimed invention advances existing knowledge.
Scope of the Patent: Description and Relevance
1. Patent Focus
KR20180052120 covers [e.g., a composition comprising a specific active pharmaceutical ingredient (API) in a novel formulation], with emphasis on [e.g., enhanced solubility, targeted delivery, sustained release]. It may also encompass [methods of manufacturing, therapeutic indications, or dosage regimes].
The claims likely extend to both the composition and the methods of use, possibly including combinations with other drugs, broadening the patent’s protective scope.
2. Geographical and Technical Scope
As a South Korean patent, this patent's scope is confined primarily within South Korea but can influence global patent strategies if filed similarly elsewhere via PCT or direct applications. The patent landscape in this domain typically involves overlapping innovation across jurisdictions such as China, Japan, the US, and Europe, where similar formulations or methods are often patented.
Claims Analysis:
Claims define the boundary of patent protection. In pharmaceuticals, claims may be categorized as independent, dependent, product, process, or use claims.
1. Independent Claims
The core claims likely describe the broadest inventive aspect, such as:
-
A pharmaceutical composition comprising [specific API] in a [specific formulation], characterized by [a particular feature, e.g., particle size, coating material, or molecular weight].
-
A method for treating [disease] comprising administering the composition according to claim 1.
These claims set the foundational scope, aiming to prevent competitors from producing similar formulations.
2. Dependent Claims
Dependent claims narrow the scope to particular embodiments or specific parameters, such as:
-
*The composition of claim 1, wherein [the API concentration] is [specified range].
-
*The method of claim 2, wherein the treatment is for [specific condition or patient group].
The strategic inclusion of dependent claims enhances patent robustness by covering various embodiments.
3. Key Claim Strengths and Vulnerabilities
-
Strengths:
Broad independent claims covering core novel features set a strong foundation. Claims emphasizing unexpected technical advantages—e.g., improved bioavailability—add inventive merit.
-
Weaknesses:
Prior art focusing on similar formulations or methods could circumscribe the claims' novelty if not sufficiently distinguished. Claim language must be precise to withstand validity challenges.
Patent Landscape Analysis
1. Prior Art and Similar Patents
The landscape for pharmaceutical patents in Korea reveals an active field, with numerous filings related to [e.g., drug delivery systems, specific chemical entities, or treatment protocols]. Existing patents, such as KR Patent No. XYZ or international equivalents, may target similar formulations, requiring KR20180052120 to demonstrate clear inventive step.
2. Overlap with International Patents
Given South Korea’s active participation in the global patent system through the Patent Cooperation Treaty (PCT), the invention’s scope may be mirrored or challenged by filings in major jurisdictions. Key considerations include:
3. Patent Life Cycle and Strategic Position
Filed in [year, 2018], the patent likely has protection until [2038], considering 20 years post-filing. Its strategic value involves:
-
Blocking competitor entry in Korea.
-
Facilitating licensing or partnership opportunities.
-
Serving as a basis for international patent prosecution.
Regulatory and Commercial Implications
A patent’s scope directly impacts market exclusivity and negotiation leverage. Broad claims can deter potential entrants but risk invalidation if overly ambitious. Narrow claims may be easier to defend but limit commercial reach.
The patent’s focus on new formulations or methods potentially enhances therapeutic differentiation, influencing regulatory approval processes and market access strategies within Korea and beyond.
Conclusion
KR20180052120 exemplifies a strategically formulated patent within South Korea’s vibrant pharmaceutical patent landscape. Its scope hinges on well-defined claims that encompass a novel composition or delivery method likely to address unmet medical needs. Its robustness, however, depends on precise claim language and differentiation from prior art. As with all pharmaceutical patents, ongoing vigilance over patent validity, potential overlaps, and the evolving global protection strategies remains critical.
Key Takeaways
-
Precise Claim Drafting: Clear, broad independent claims supported by detailed dependent claims maximize protection.
-
Patent Landscape Awareness: Competitors' patents must be scrutinized to sustain validity and avoid infringement.
-
Strategic Positioning: The patent enhances market exclusivity if claims are sufficiently broad and novel, supporting commercialization efforts.
-
Global Strategy: International filings complement the South Korean patent, guarding against competitors outside Korea.
-
Continuous Monitoring: Patent validity and competitive positioning require ongoing analysis, particularly regarding emerging prior art and legal challenges.
FAQs
1. What makes a patent claim in pharmaceuticals particularly strong?
Claims that are broad yet specific enough to distinguish the invention from prior art, supported by detailed descriptions, generally provide stronger protection in pharmaceuticals.
2. How does South Korea’s patent law influence pharmaceutical patent scope?
South Korea requires that claims demonstrate novelty, inventive step, and industrial applicability. The patent office scrutinizes claims against prior art, emphasizing clarity and support, which influences claim breadth.
3. Can this patent be challenged in South Korea?
Yes. Competitors or third parties can file oppositions or invalidation proceedings citing prior art or lack of inventive step, especially if claims are too broad or overlap with existing patents.
4. How does this patent landscape impact drug commercialization in Korea?
A robust patent estate affords exclusive marketing rights, incentivizing investment, and deterring infringement, thus supporting higher returns on R&D investments.
5. What are potential strategies to expand the patent’s protection?
Filing divisional or continuation applications, pursuing international patents through PCT, and securing patent amendments to cover additional embodiments can extend coverage.
Sources:
[1] Korean Intellectual Property Office (KIPO). Patent Database.
[2] WIPO PATENTSCOPE. Patent landscape reports.
[3] South Korea Patent Act and Examination Guidelines.
